Contrez 0,02 mg, 3,0 mg Tablet
PDF Leaflet Revision Date: 25/10/2022
Clinical Summary
Quick overview from the medicine insert
Indication
Oral contraceptive; treatment of moderate acne and PMDD.
Dosage (summary)
One tablet daily for 28 days, starting on day 1 of menstrual cycle.
Special Populations
- Elderly
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Not indicated during pregnancy; not recommended during breastfeeding.
Key Drug Interactions
- Enzyme inducers (e.g., phenytoin, rifampicin)
- CYP3A4 inhibitors (e.g., ketoconazole)
Contraindications
- Hypersensitivity
- VTE risk
- Severe hepatic disease
- Severe renal insufficiency
- Pregnancy
Common side effects
- Nausea
- Headache
- Dizziness
- Breast pain
- Mood changes
Counselling Points
- Take at the same time daily
- Use barrier method if tablets missed
- Report any severe side effects
Serious warnings
- Risk of VTE and ATE
- Monitor for hypertension
- Possible liver tumours
Important Disclaimer
The Contrez 0,02 mg, 3,0 mg Tablet professional information leaflet below is the property of Innovata Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
